Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Metronidazole 💬[1] Metronidazole (2-methyl-5-nitroimidazole-1-ethanol)[3] Flagyl; Metronidazol; Metronidazole--[7] 46, 51, 63, 94, 96, 97, 291 💬
2 Ethanolamine oleate 💬
(Ethanolamine oleate (USAN))
[1] Ethanolamine oleate (Ethanolamine Oleate Inj 50mg/ml)[1] Ethanolamine oleate--[1] 279 💬
3 Dipivefrin 💬[1] Dipivefrin (1--2-methylamino-1-ethanol)[2] Dipivefrin; Dipivefrine[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
4 Ethanol 💬
(Ethanol (JP18), Ethanol (TN))
[1] Ethanol (Loft and Bear Hand Wash with Ethanol Alcohol 128 oz/ 1 gallon)[3] Alcohol; Ethanol; PREDNISONE--[5] 58, 97, 279, 280, 298 💬
5 Clenbuterol 💬[1] Clenbuterol (1--2-tert-butylamino-ethanol)[1] Clenbuterol[1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 1, 2, 6, 256 💬
6 Deanol 💬[1] Deanol (2-ethanol)[1] Deanol--[1] 6 💬
7 Hydroxychloroquine 💬[1] Hydroxychloroquine (2-ethanol)[3] Hydroxychloroquine; HYDROXYCHLOROQUINE SULFATE; PLAQUENIL--[27] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
8 Palmidrol 💬[1] Palmidrol (Palmitoyl ethanolamide)[1] Palmitoylethanolamide--[1] 2 💬